Although the impact of smoking on CYP1A2 expression was reliably evaluated in the patients with psychiatric disorders, oral contraceptives were not applied in these patients; therefore, no conclusion on the CYP1A2 activity-reducing effect of these drugs could be drawn. The gene discussed is CYP1A2; the disease is psychiatric disorder.